Stem Cell Cryopreservation Market Report 2026

The stem cell cryopreservation market size has grown rapidly in recent years. It will grow from $4.17 billion in 2025 to $4.99 billion in 2026 at a compound annual growth rate (CAGR) of 19.8%. The growth in the historic period can be attributed to expansion of stem cell banking initiatives, increasing use of cryopreservation in research, growth in ivf and fertility treatments, rising demand for long-term cell storage, improvements in cryogenic storage technologies.

The stem cell cryopreservation market size is expected to see rapid growth in the next few years. It will grow to $10.17 billion in 2030 at a compound annual growth rate (CAGR) of 19.5%. The growth in the forecast period can be attributed to increasing adoption of regenerative medicine therapies, growing investments in biobanking infrastructure, rising demand for personalized medicine storage solutions, expansion of clinical cell therapy pipelines, increasing focus on standardized storage protocols. Major trends in the forecast period include increasing demand for long-term stem cell storage, rising use of advanced cryoprotectants, growing adoption of automated cryopreservation systems, expansion of stem cell banking services, enhanced focus on cell viability preservation.

The increasing prevalence of degenerative diseases is expected to drive the growth of the stem cell cryopreservation market in the coming years. Degenerative diseases are medical conditions in which the structure or function of tissues or organs progressively deteriorates over time, often resulting in loss of normal function. The rise in degenerative diseases is largely attributed to the aging population, as older individuals are more susceptible to cellular and tissue deterioration that leads to such conditions. Stem cell cryopreservation enables long-term storage of viable stem cells, providing a reliable source for regenerative therapies aimed at repairing and replacing damaged tissues. For instance, in March 2023, the Alzheimer's Association reported that approximately 6.7 million Americans aged 65 and older were living with Alzheimer's dementia, a number projected to reach 13.8 million by 2060. Therefore, the growing prevalence of degenerative diseases is fueling the stem cell cryopreservation market.

Major companies in the stem cell cryopreservation market are focusing on innovative solutions such as advanced cryopreservation media and automation-friendly freezing systems to improve post-thaw cell viability and accelerate stem cell therapy development. Advanced cryopreservation media are formulated to protect stem cells during freezing and thawing, maintaining their viability and function, while automation-friendly freezing systems enable scalable, reproducible, and hands-free processing of large cell batches. For instance, in April 2024, Pluristyx, Inc., a US-based biotechnology company, launched PluriFreeze, a proprietary cryopreservation medium designed to enhance freezing and thawing of pluripotent stem cells and other sensitive cell types. This medium, made entirely from synthetic, animal-origin-free components with low viscosity, ensures high post-thaw viability and functional integrity. It is complemented by the DMSO-free PluriPrep wash solution for extended processing times and integrates seamlessly with platforms such as PluriBank, providing scalable and reliable solutions from research to clinical applications.

In April 2025, BioLife Solutions Inc., a US-based healthcare technology company, acquired a 90% stake in PanTHERA CryoSolutions Inc. for $21.53 million. Through this acquisition, BioLife Solutions aims to enhance its technological capabilities in stem cell cryopreservation and expand its presence in advanced biobanking solutions. PanTHERA CryoSolutions Inc. is a Canada-based healthcare technology company specializing in innovative cryopreservation services for stem cells and other cellular therapies.

Major companies operating in the stem cell cryopreservation market are Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Lonza Group Ltd., Sartorius AG, Eppendorf SE, Vitalant Inc., BioLife Solutions Inc., Cryoviva Biotech Private Limited., HiMedia Laboratories Private Limited, Cryo-Cell International Inc., Celularity Inc., PromoCell GmbH, Creative Biolabs Inc., StemCyte Inc., Reprocell Inc., OriGen Biomedical Inc., American CryoStem Corporation, Ossium Health Inc., Pluristyx Inc.

North America was the largest region in the stem cell cryopreservation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell cryopreservation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the stem cell cryopreservation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the stem cell cryopreservation market by increasing costs of imported cryogenic freezers, storage vessels, liquid nitrogen systems, freezing media, and monitoring equipment. Biopharmaceutical companies, research institutes, and ivf clinics in North America and Europe are most affected due to reliance on imported cryogenic infrastructure, while Asia-Pacific faces higher equipment manufacturing costs. These tariffs are raising capital investment requirements and storage service costs. However, they are also driving local equipment production, regional supply chain development, and innovation in cost-efficient cryopreservation technologies.

The stem cell cryopreservation market research report is one of a series of new reports that provides stem cell cryopreservation market statistics, including stem cell cryopreservation industry global market size, regional shares, competitors with a stem cell cryopreservation market share, detailed stem cell cryopreservation market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell cryopreservation industry. This stem cell cryopreservation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Stem cell cryopreservation is the process of preserving stem cells at ultra-low temperatures to maintain their viability and biological functions for long-term use. This method enables safe storage of stem cells for future therapeutic applications, research, or transplantation.

The main types of stem cell cryopreservation include embryonic stem cells, adult stem cells, and induced pluripotent stem cells. Embryonic stem cells are pluripotent cells derived from the inner cell mass of a blastocyst and can differentiate into any cell type in the body. Applications include cell freezing media, equipment, and consumables, serving end users such as biopharmaceutical companies, research institutes, blood banks, and in vitro fertilization (IVF) clinics.

The stem cell cryopreservation market consists of revenues earned by entities by providing services such as collection and processing of stem cells, long-term storage and preservation, quality testing and viability assessment, regulatory compliance and documentation services, and insurance and risk management services. The market value includes the value of related goods sold by the service provider or included within the service offering. The stem cell cryopreservation market also includes sales of ultra-low-temperature storage equipment, rewarming devices, storage and retrieval systems, and ancillary support products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.